456 related articles for article (PubMed ID: 28420434)
1. The neuroprotective effects of human bone marrow mesenchymal stem cells are dose-dependent in TNBS colitis.
Robinson AM; Rahman AA; Miller S; Stavely R; Sakkal S; Nurgali K
Stem Cell Res Ther; 2017 Apr; 8(1):87. PubMed ID: 28420434
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic guinea pig mesenchymal stem cells ameliorate neurological changes in experimental colitis.
Stavely R; Robinson AM; Miller S; Boyd R; Sakkal S; Nurgali K
Stem Cell Res Ther; 2015 Dec; 6():263. PubMed ID: 26718461
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells and conditioned medium avert enteric neuropathy and colon dysfunction in guinea pig TNBS-induced colitis.
Robinson AM; Sakkal S; Park A; Jovanovska V; Payne N; Carbone SE; Miller S; Bornstein JC; Bernard C; Boyd R; Nurgali K
Am J Physiol Gastrointest Liver Physiol; 2014 Dec; 307(11):G1115-29. PubMed ID: 25301186
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective Potential of Mesenchymal Stem Cell-Based Therapy in Acute Stages of TNBS-Induced Colitis in Guinea-Pigs.
Robinson AM; Miller S; Payne N; Boyd R; Sakkal S; Nurgali K
PLoS One; 2015; 10(9):e0139023. PubMed ID: 26397368
[TBL] [Abstract][Full Text] [Related]
5. Human adult stem cells derived from adipose tissue and bone marrow attenuate enteric neuropathy in the guinea-pig model of acute colitis.
Stavely R; Robinson AM; Miller S; Boyd R; Sakkal S; Nurgali K
Stem Cell Res Ther; 2015 Dec; 6():244. PubMed ID: 26652292
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cell treatment for enteric neuropathy in the Winnie mouse model of spontaneous chronic colitis.
Robinson AM; Stavely R; Miller S; Eri R; Nurgali K
Cell Tissue Res; 2022 Jul; 389(1):41-70. PubMed ID: 35536444
[TBL] [Abstract][Full Text] [Related]
7. Targeting eotaxin-1 and CCR3 receptor alleviates enteric neuropathy and colonic dysfunction in TNBS-induced colitis in guinea pigs.
Filippone RT; Robinson AM; Jovanovska V; Stavely R; Apostolopoulos V; Bornstein JC; Nurgali K
Neurogastroenterol Motil; 2018 Nov; 30(11):e13391. PubMed ID: 29968270
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Adipose-Derived and Bone Marrow Mesenchymal Stromal Cells in a Murine Model of Crohn's Disease.
Xie M; Qin H; Luo Q; He X; He X; Lan P; Lian L
Dig Dis Sci; 2017 Jan; 62(1):115-123. PubMed ID: 27107864
[TBL] [Abstract][Full Text] [Related]
9. Combinatorial Intervention with Mesenchymal Stem Cells and Granulocyte Colony-Stimulating Factor in a Rat Model of Ulcerative Colitis.
Tang Y; Chen Y; Wang X; Song G; Li Y; Shi L
Dig Dis Sci; 2015 Jul; 60(7):1948-57. PubMed ID: 25894931
[TBL] [Abstract][Full Text] [Related]
10. IGF-1C hydrogel improves the therapeutic effects of MSCs on colitis in mice through PGE
Cao X; Duan L; Hou H; Liu Y; Chen S; Zhang S; Liu Y; Wang C; Qi X; Liu N; Han Z; Zhang D; Han ZC; Guo Z; Zhao Q; Li Z
Theranostics; 2020; 10(17):7697-7709. PubMed ID: 32685014
[No Abstract] [Full Text] [Related]
11. Study on the interactions between transplanted bone marrow-derived mesenchymal stem cells and regulatory T cells for the treatment of experimental colitis.
Zuo D; Liu X; Shou Z; Fan H; Tang Q; Duan X; Cao D; Zou Z; Zhang L
Int J Mol Med; 2013 Dec; 32(6):1337-44. PubMed ID: 24142133
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow-derived mesenchymal stem cells mitigate chronic colitis and enteric neuropathy via anti-inflammatory and anti-oxidative mechanisms.
Stavely R; Robinson AM; Fraser S; Filippone RT; Stojanovska V; Eri R; Apostolopoulos V; Sakkal S; Nurgali K
Sci Rep; 2024 Mar; 14(1):6649. PubMed ID: 38503815
[TBL] [Abstract][Full Text] [Related]
13. [Allogeneic mesenchymal stromal cells in patients with ulcerative colitis: two years of observation].
Lazebnik LB; Kniazev OV; Konopliannikov AG; Parfenov AI; Ruchkina IN; Mikhaĭlova ZF; Tsaregorodtseva TM; Khomeriki SG; Rogozina VA; Gudkova RB; Shcherbakov PL; Konopliannikova OA
Eksp Klin Gastroenterol; 2010; (11):3-15. PubMed ID: 21485508
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine.
Sala E; Genua M; Petti L; Anselmo A; Arena V; Cibella J; Zanotti L; D'Alessio S; Scaldaferri F; Luca G; Arato I; Calafiore R; Sgambato A; Rutella S; Locati M; Danese S; Vetrano S
Gastroenterology; 2015 Jul; 149(1):163-176.e20. PubMed ID: 25790743
[TBL] [Abstract][Full Text] [Related]
15. A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6.
Yang S; Liang X; Song J; Li C; Liu A; Luo Y; Ma H; Tan Y; Zhang X
Stem Cell Res Ther; 2021 May; 12(1):315. PubMed ID: 34051868
[TBL] [Abstract][Full Text] [Related]
16. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
[TBL] [Abstract][Full Text] [Related]
17. TSG-6 released from intraperitoneally injected canine adipose tissue-derived mesenchymal stem cells ameliorate inflammatory bowel disease by inducing M2 macrophage switch in mice.
Song WJ; Li Q; Ryu MO; Ahn JO; Bhang DH; Jung YC; Youn HY
Stem Cell Res Ther; 2018 Apr; 9(1):91. PubMed ID: 29625582
[TBL] [Abstract][Full Text] [Related]
18. Human umbilical cord mesenchymal stem cells ameliorate mice trinitrobenzene sulfonic acid (TNBS)-induced colitis.
Liang L; Dong C; Chen X; Fang Z; Xu J; Liu M; Zhang X; Gu DS; Wang D; Du W; Zhu D; Han ZC
Cell Transplant; 2011; 20(9):1395-408. PubMed ID: 21396175
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy of mesenchymal stromal cells and sulfasalazine attenuates trinitrobenzene sulfonic acid induced colitis in the rat: The S1P pathway.
Yousefi-Ahmadipour A; Rashidian A; Mirzaei MR; Farsinejad A; PourMohammadi-Nejad F; Ghazi-Khansari M; Ai J; Shirian S; Allahverdi A; Saremi J; Ebrahimi-Barough S
J Cell Physiol; 2019 Jul; 234(7):11078-11091. PubMed ID: 30580446
[TBL] [Abstract][Full Text] [Related]
20. Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis?
Gonçalves Fda C; Schneider N; Pinto FO; Meyer FS; Visioli F; Pfaffenseller B; Lopez PL; Passos EP; Cirne-Lima EO; Meurer L; Paz AH
World J Gastroenterol; 2014 Dec; 20(48):18228-39. PubMed ID: 25561790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
